EVIDENCE BY CONDITION
A condition is not
a marketing claim.
We examine the exact formulation, population, comparator, outcome, and adverse effects behind medical-cannabis claims. These reviews explain evidence; they do not prescribe treatment.

Cannabis and chronic pain: what the evidence actually measures
Some cannabinoid formulations produce small short-term changes for some pain outcomes, alongside adverse effects and major evidence gaps.

Cannabinoids and chemotherapy nausea: where they fit
Approved cannabinoid medicines exist for treatment-related nausea, but modern guidelines distinguish refractory symptoms from first-line care.

Cannabis and multiple sclerosis: evidence for spasticity
What studies of cannabinoids for MS spasticity show, including the formulation studied, treatment limits, and clinical guidance.

CBD and epilepsy: evidence, Epidiolex, and seizure disorders
What CBD epilepsy trials found, which seizure disorders Epidiolex is approved for, and why retail CBD is not interchangeable.

Cannabis and CBD for sleep: what the evidence shows
Does cannabis or CBD help with sleep? Systematic reviews find small signals, inconsistent products, and substantial uncertainty for insomnia.

Cannabis and ADHD: does the evidence support treatment?
Does cannabis help ADHD? Self-reported relief is not clinical proof, and current ADHD guidelines do not recommend cannabis treatment.

Cannabis and blood pressure: heart effects and cardiovascular risk
How cannabis can affect blood pressure and heart rate, what observational studies report, and why long-term cardiovascular risk remains uncertain.